| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 04/15/2009 | EP2048134A1 Meptazinol biligand derivatives and/or their salts, preparation method and uses thereof |
| 04/15/2009 | EP2047853A1 The application of marine steroid in preparing the medicine of treating neurons damaging |
| 04/15/2009 | EP2047852A1 Use of flumazenil in the production of a medicament for the treatment of depressive disorders |
| 04/15/2009 | EP2047845A1 Adhesive preparation |
| 04/15/2009 | EP2046823A1 Post-translationally modified neurotrophins |
| 04/15/2009 | EP2046800A1 6-carboxy-normorphinan derivatives, synthesis and uses thereof |
| 04/15/2009 | EP2046791A2 Urea derivatives of tropane, their preparation and their therapeutic application |
| 04/15/2009 | EP2046783A2 Imidazol-pyrimidine derivatives for treatment of diseases related to glycogen synthase kinase (gsk3) |
| 04/15/2009 | EP2046782A2 Imidazolylpyrimidine derivatives for treatment of diseases related to glycogen synthase kinase (gsk3) |
| 04/15/2009 | EP2046777A2 Amorphous eletriptan hydrobromide and process for preparing it and other forms of eletriptan hydrobromide |
| 04/15/2009 | EP2046775A1 N-(aminoheteroaryl)-1h-indole-2-carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 04/15/2009 | EP2046767A2 Process for preparing diaminophenothiazinium compounds |
| 04/15/2009 | EP2046766A1 Agonists of the sphingosine- 1- phosphate receptor (slp) |
| 04/15/2009 | EP2046761A2 Macrocyclic compounds useful as bace inhibitors |
| 04/15/2009 | EP2046760A1 Macrocyclic lactams |
| 04/15/2009 | EP2046749A1 Pharmaceutically acceptable salt and polymorphic forms of flupirtine maleate |
| 04/15/2009 | EP2046747A1 Substituted aminomethyl benzamide compounds |
| 04/15/2009 | EP2046393A2 Controlled release of phenolic opioids |
| 04/15/2009 | EP2046386A2 Peptide compounds for the treatment of hyperexcitability disorders and diseases associated with ion channel dysfunction |
| 04/15/2009 | EP2046370A2 Treatment of pain by use of a single chain polypeptide fusion protein |
| 04/15/2009 | EP2046364A2 Use of wnt5a for inhibiting scarring |
| 04/15/2009 | EP2046358A1 Induction of analgesia in neuropathic pain |
| 04/15/2009 | EP2046354A2 Alphanizomenon flos aquae preparation, extracts and purified components thereof for the treatment of neurological, neurodegenerative and mood disorders |
| 04/15/2009 | EP2046335A2 Methods and pharmaceutical preparations for contributing to the treatment of chemotherapy-induced neuropathy |
| 04/15/2009 | EP2046333A2 Thiozolidinedione derivatives as p13 kinase inhibitors |
| 04/15/2009 | EP2046332A2 Concentrated methotrexate solutions |
| 04/15/2009 | EP2046327A1 Medical use of cyclin dependent kinases inhibitors |
| 04/15/2009 | EP2046320A2 Anticonvulsive pharmaceutical compositions |
| 04/15/2009 | EP1896021B1 Solid pharmaceutical preparation containing (r)-(-)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chroman |
| 04/15/2009 | EP1703909B1 1-benzoyl-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses |
| 04/15/2009 | EP1603533B1 Opioid delivery system |
| 04/15/2009 | EP1551763B1 Method for the preparation of a silicic acid comprising extrudate, said extrudate, its use and a pharmaceutical composition comprising the said extrudate |
| 04/15/2009 | EP1542668B1 Aripiprazole complex formulation and method |
| 04/15/2009 | EP1505148B1 Methods of screening for agonistic antibodies |
| 04/15/2009 | EP1480678B1 Treatment of ophthalmic disorders using urea and urea derivatives |
| 04/15/2009 | EP1363635B1 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors |
| 04/15/2009 | EP1311532B1 Oestrogen-17-sulphamates as inhibitors of steroid sulphatase |
| 04/15/2009 | EP1297849B1 Remedial agent for optic nerve diseases |
| 04/15/2009 | EP1267882B1 Prostaglandins for the treatment of eye disease caused by light irradiation like photoretinitis |
| 04/15/2009 | EP1244648B1 Chemokine receptor binding heterocyclic compounds |
| 04/15/2009 | EP1012267B1 An antisense oligonucleotide preparation method |
| 04/15/2009 | EP0792292B2 Estrogen receptor |
| 04/15/2009 | CN101410408A A process for concentration of a polypeptide |
| 04/15/2009 | CN101410402A Buprenorphine derivatives and uses thereof |
| 04/15/2009 | CN101410401A Spiro[benzopyran] or spiro[benzofuran] derivatives which inhibit the sigma receptor |
| 04/15/2009 | CN101410393A Novel heteroaryl substituted benzothiazoles |
| 04/15/2009 | CN101410392A Amide substituted quinolines |
| 04/15/2009 | CN101410385A Benzothiazoles having histamine H3 receptor activity |
| 04/15/2009 | CN101410378A Malonamide derivatives as gamma secretase inhibitors |
| 04/15/2009 | CN101410118A Treatment of pain |
| 04/15/2009 | CN101410117A New therapeutic comibinations for the treatment or prevention of psychotic disorders |
| 04/15/2009 | CN101410115A Compositions containing riboflavin and sesamin-class compounds |
| 04/15/2009 | CN101410113A Methods for treating cognitive and other disorders |
| 04/15/2009 | CN101410112A New therapeutic combinations for the treatment of depression |
| 04/15/2009 | CN101410110A Varenicline standards and impurity controls |
| 04/15/2009 | CN101410107A MIF inhibitors |
| 04/15/2009 | CN101410106A Method for treating nervous system disorders and conditions |
| 04/15/2009 | CN101407785A Nestin-expressing hair follicle stem cells |
| 04/15/2009 | CN101407456A Effective ingredient having beta-secretase inhibition effect in Homalonema occulta |
| 04/15/2009 | CN101406722A Foot part article with pedicure function |
| 04/15/2009 | CN101406703A Transdermal analgesic systems with reduced abuse potential |
| 04/15/2009 | CN101406701A Adjuvant capable of improving dendritic cell vaccine efficiency |
| 04/15/2009 | CN101406695A Pharmaceutical composition for promoting axon regeneration after spinal cord damage and behavior function recovery |
| 04/15/2009 | CN101406690A Medicament for promoting regeneration and repair after neurologic damage |
| 04/15/2009 | CN101406680A Compound syrup paste for epilepsy |
| 04/15/2009 | CN101406679A Chinese medicinal composition for detoxification and products thereof |
| 04/15/2009 | CN101406674A Quality control method of Ninggong tablet containing bezoar |
| 04/15/2009 | CN101406670A Chinese patent medicine for treating brain injury coma |
| 04/15/2009 | CN101406668A Chinese medicinal composition for treating headache and dizzy, and preparation method thereof |
| 04/15/2009 | CN101406631A Medicament for treating hyperkinetic symptom of children |
| 04/15/2009 | CN101406616A Pharmaceutical combination for preventing birth-defect and improving memory and intelligence |
| 04/15/2009 | CN101406615A Pharmaceutical combination for preventing birth-defect and improving memory |
| 04/15/2009 | CN101406614A Pharmaceutical combination for preventing birth-defect and improving memory |
| 04/15/2009 | CN101406593A Cigarette paste for giving up drugs |
| 04/15/2009 | CN101406580A Anticancer pain-relieving Chinese medicine and preparation method thereof |
| 04/15/2009 | CN101406578A Plaster for curing facial paralysis |
| 04/15/2009 | CN101406549A Pharmaceutical combination for preventing birth-defect and improving memory and intelligence |
| 04/15/2009 | CN101406518A Pills for treating sciatica and preparation method thereof |
| 04/15/2009 | CN101406507A Pharmaceutical combination for preventing birth-defect and improving memory and intelligence |
| 04/15/2009 | CN101406506A Pharmaceutical combination for preventing birth-defect and improving memory |
| 04/15/2009 | CN101406505A Pharmaceutical combination for preventing birth-defect and improving memory |
| 04/15/2009 | CN101406503A Method for treating headache |
| 04/15/2009 | CN101406500A Medicament for treating headache and migraine, and preparation method thereof |
| 04/15/2009 | CN101406492A Compound Cordyceps sinensis oil soft capsule and preparation technique |
| 04/15/2009 | CN101406486A Method for preparing maggot health-care oral liquid |
| 04/15/2009 | CN101406474A Nalmefene injection and preparation method thereof |
| 04/15/2009 | CN101406473A Use of dihydropyrimidine compound and pharmaceutical composition containing the same |
| 04/15/2009 | CN101406470A Use of heterocyclic ring derivative of pyridine and pharmaceutical composition containing the same |
| 04/15/2009 | CN101406469A Use of GAL3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods |
| 04/15/2009 | CN101406468A Use of benzofuryl derivative and pharmaceutical composition containing the same |
| 04/15/2009 | CN101406465A Combination of a serotonin reuptake inhibitor and a 5-HT2C antagonist, inverse agonist or partial agonist |
| 04/15/2009 | CN101406290A Three-root tea |
| 04/15/2009 | CN101406284A Pharmaceutical combination for preventing birth-defect and improving memory |
| 04/15/2009 | CN100478340C Pyrrole-2, 5-dithione derivatives as liver X receptor modulators |
| 04/15/2009 | CN100478029C Immunomodulatory human MHC class II antigen-binding polypeptides |
| 04/15/2009 | CN100478001C Tribulus terrestris extraction and its preparation method and use |
| 04/15/2009 | CN100478000C Application of valeriana wallichii and its extract in preparation of medicine for treating anxiety neurosis |
| 04/15/2009 | CN100477994C Meloxicam containing skin topical paste formulation |
| 04/15/2009 | CN100477992C Substituted piperazine and piperidine calcium channel blockers |
| 04/15/2009 | CN100477988C Use of pogostemonis alkane type sesquiterpene compound as vegetative female sex normone |